ConMed Corp. (NYSE: CNMD), a surgical-device maker originally based in the greater Utica region, recently announced that its board of directors has declared a quarterly cash dividend of 20 cents per share for the second quarter of 2025.
The dividend is payable on July 3, to all shareholders of record as of June 13. At the company’s current stock price, the payment yields about 1.4 percent on an annual basis.
ConMed is a medical technology company that provides devices and equipment for surgical procedures. The firm’s products are used by surgeons and other health-care professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology.
(Sponsored)
The OBBBA Resurrects the Immediate R&E Expense Deduction
Under the Tax Cuts and Jobs Act (TCJA), businesses, including manufacturers, have been required since 2022 to amortize domestic Section 174 research and experimental (R&E) costs over five years, rather
The End of Non-Compete Agreements in New York?
Among the tidal wave of changes impacting employers, ranging from updated anti-harassment laws, restrictions on absenteeism policies and new pay transparency rules, New York is now poised to restrict the
Based in Largo, Florida since 2021, ConMed still operates a facility on French Road in New Hartford, where it was formerly headquartered.
